tradingkey.logo

Rockwell Medical Inc

RMTI
View Detailed Chart

1.330USD

0.000
Close 09/19, 16:00ETQuotes delayed by 15 min
45.79MMarket Cap
LossP/E TTM

Rockwell Medical Inc

1.330

0.000
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

-17.90%

1 Month

+26.67%

6 Months

-24.43%

Year to Date

-34.80%

1 Year

-67.91%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
87 / 175
Overall Ranking
261 / 4720
Industry
Pharmaceuticals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Buy
Current Rating
4.000
Target Price
+200.75%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 39.39% year-on-year.
Undervalued
The company’s latest PE is -23.37, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.15M shares, decreasing 10.66% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.21M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.92.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
Ticker SymbolRMTI
CompanyRockwell Medical Inc
CEODr. Mark Strobeck, Ph.D.
Websitehttps://www.rockwellmed.com/
KeyAI